Arecor Therapeutics plc announced that Susan Lowther has decided to step down from her role as Company Secretary and as a Board Director, to pursue new opportunities. A search for Susan's successor is underway and her last day with Arecor is expected to be on the 22 July, to ensure an effective handover.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131 GBX | 0.00% | -4.03% | -28.22% |
May. 16 | EARNINGS AND TRADING: Michelmersh continues with positive order intake | AN |
May. 16 | Transcript : Arecor Therapeutics plc, 2023 Earnings Call, May 16, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.22% | 50.84M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- AREC Stock
- News Arecor Therapeutics plc
- Arecor Therapeutics plc Announces Stepping Down of Susan Lowther as Company Secretary and as A Board Director, Effective from July 22,2024